Your browser doesn't support javascript.
loading
Coxsackievirus infection induces direct pancreatic ß-cell killing but poor anti-viral CD8+ T-cell responses.
Vecchio, Federica; Carré, Alexia; Korenkov, Daniil; Zhou, Zhicheng; Apaolaza, Paola; Tuomela, Soile; Burgos-Morales, Orlando; Snowhite, Isaac; Perez-Hernandez, Javier; Brandao, Barbara; Afonso, Georgia; Halliez, Clémentine; Kaddis, John; Kent, Sally C; Nakayama, Maki; Richardson, Sarah J; Vinh, Joelle; Verdier, Yann; Laiho, Jutta; Scharfmann, Raphael; Solimena, Michele; Marinicova, Zuzana; Bismuth, Elise; Lucidarme, Nadine; Sanchez, Janine; Bustamante, Carmen; Gomez, Patricia; Buus, Soren; You, Sylvaine; Pugliese, Alberto; Hyoty, Heikki; Rodriguez-Calvo, Teresa; Flodstrom-Tullberg, Malin; Mallone, Roberto.
Afiliación
  • Vecchio F; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Carré A; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Korenkov D; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Zhou Z; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Apaolaza P; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Tuomela S; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Burgos-Morales O; Center for Infectious Medicine, Department of medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Snowhite I; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Perez-Hernandez J; Diabetes Research Institute, Leonard Miller School of Medicine, University of Miami, FL, USA.
  • Brandao B; Department of Diabetes Immunology, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, CA, USA.
  • Afonso G; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Halliez C; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Kaddis J; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Kent SC; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Nakayama M; Department of Diabetes Immunology, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, CA, USA.
  • Richardson SJ; Department of Diabetes and Cancer Discovery Science, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, CA, USA.
  • Vinh J; University of Massachusetts Medical Chan School, Diabetes Center of Excellence, Department of Medicine, Worcester, MA, USA.
  • Verdier Y; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA.
  • Laiho J; Islet Biology Exeter (IBEx), Exeter Centre of Excellence for Diabetes Research (EXCEED), Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK.
  • Scharfmann R; ESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UMR8249, Paris, France.
  • Solimena M; ESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UMR8249, Paris, France.
  • Marinicova Z; Tampere University, Faculty of Medicine and Health Technology and Fimlab Laboratories, Tampere, Finland.
  • Bismuth E; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Lucidarme N; Paul Langerhans Institute, Technical University Dresden, Germany.
  • Sanchez J; Paul Langerhans Institute, Technical University Dresden, Germany.
  • Bustamante C; Assistance Publique Hôpitaux de Paris, Service d'Endocrinologie Pédiatrique, Robert Debré Hospital, Paris, France.
  • Gomez P; Assistance Publique Hôpitaux de Paris, Service de Pédiatrie, Jean Verdier Hospital, Bondy, France.
  • Buus S; Department of Pediatrics, Division of pediatric Endocrinology, Leonard Miller School of Medicine, University of Miami, FL, USA.
  • You S; Department of Pediatrics, Division of pediatric Endocrinology, Leonard Miller School of Medicine, University of Miami, FL, USA.
  • Pugliese A; Panum Institute, Department of International Health, Immunology and Microbiology, Copenhagen, Denmark.
  • Rodriguez-Calvo T; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Flodstrom-Tullberg M; Indiana Biosciences Research Institute, Indianapolis, IN, USA.
  • Mallone R; Diabetes Research Institute, Leonard Miller School of Medicine, University of Miami, FL, USA.
bioRxiv ; 2023 Aug 21.
Article en En | MEDLINE | ID: mdl-37662376
ABSTRACT
Coxsackievirus B (CVB) infection of pancreatic ß cells is associated with ß-cell autoimmunity. We investigated how CVB impacts human ß cells and anti-CVB T-cell responses. ß cells were efficiently infected by CVB in vitro, downregulated HLA Class I and presented few, selected HLA-bound viral peptides. Circulating CD8+ T cells from CVB-seropositive individuals recognized only a fraction of these peptides, and only another sub-fraction was targeted by effector/memory T cells that expressed the exhaustion marker PD-1. T cells recognizing a CVB epitope cross-reacted with the ß-cell antigen GAD. Infected ß cells, which formed filopodia to propagate infection, were more efficiently killed by CVB than by CVB-reactive T cells. Thus, our in-vitro and ex-vivo data highlight limited T-cell responses to CVB, supporting the rationale for CVB vaccination trials for type 1 diabetes prevention. CD8+ T cells recognizing structural and non-structural CVB epitopes provide biomarkers to differentially follow response to infection and vaccination.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2023 Tipo del documento: Article País de afiliación: Francia
...